As these differences in the ECM landscape are likely to be significant, this raises the possibility of using their changes in expression levels as circulating biomarkers of HF diagnosis and severity. 1.5.
← all excerpts
Circulating Non-Coding RNAs as Indicators of Fibrosis and Heart Failure Severity.
1
—
—